Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Item
http://www.wikidata.org/entity/Q36513512
Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritisTofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cellsEfficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study.Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.JAK inhibitors in dermatology: The promise of a new drug class.Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program.Tofacitinib: A Review in Rheumatoid Arthritis.Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial.European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies.Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis.Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.Anti-rheumatoid activity of ethanolic extract of Sesamum indicum seed extract in Freund's complete adjuvant induced arthritis in Wistar albino rats.
P2860

Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Item
http://www.wikidata.org/entity/Q36513512
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tofacitinib, an oral Janus kin ...... bel, long-term extension study
@ast
Tofacitinib, an oral Janus kin ...... bel, long-term extension study
@en
type
label
Tofacitinib, an oral Janus kin ...... bel, long-term extension study
@ast
Tofacitinib, an oral Janus kin ...... bel, long-term extension study
@en
prefLabel
Tofacitinib, an oral Janus kin ...... bel, long-term extension study
@ast
Tofacitinib, an oral Janus kin ...... bel, long-term extension study
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Tofacitinib, an oral Janus kin ...... bel, long-term extension study
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P932